{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:34:20Z","timestamp":1779086060676,"version":"3.51.4"},"reference-count":49,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the accuracy of risk prediction models and scores for diagnosing ovarian cancer in premenopausal women presenting to secondary care with symptoms and abnormal test results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Secondary care in 23 hospitals in the UK between June 2015 and March 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Premenopausal women presenting with non-specific symptoms, and raised serum levels of cancer antigen 125 or abnormal imaging results, were prospectively recruited, predominantly referred through the NHS urgent suspected cancer pathway from primary care. A head-to-head comparison of the accuracy of the six risk prediction models and scores was conducted using donated blood and ultrasound scans performed by NHS staff trained in the use of International Ovarian Tumour Analysis (IOTA) imaging terminology. The index tests used were Risk of Malignancy Index 1 (with pre-stated thresholds of 200, 250), Risk of Malignancy Algorithm (7.4%, 11.4%, 12.5%, 13.1%), IOTA Assessment of Different Neoplasias in the adnEXa (ADNEX) (3%, 10%), IOTA simple rules risk model (3%, 10%), IOTA simple rules, and cancer antigen 125 (CA 125, 87 IU\/mL). Participants were classified as having primary invasive ovarian cancer versus having benign or normal pathology according to the reference standard determined from surgical specimens or biopsies by histology or cytology, if undertaken, or else at 12 month follow-up. After June 2018, because of covid restrictions and concerns about sample size, recruitment was restricted to only women undergoing surgery within three months of presentation to clinic (in whom ovarian cancer was more likely).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Diagnostic accuracy at predicting primary invasive ovarian cancer versus benign or normal histology, assessed by analysing the sensitivity, specificity, C index, area under receiver operating characteristic curve, positive and negative predictive values, and calibration plots in participants with conclusive reference standard results and available index test data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>88 of 1211 premenopausal women received diagnoses of primary ovarian cancer: 49 of 857 women in the pre-June 2018 cohort (prevalence of 5.7%) and 39 of 354 women in the post-June 2018 cohort (11.0%). For the diagnosis of primary ovarian cancer (n=799 women, after exclusion of 58 other diagnoses), Risk of Malignancy Index 1 at the 250 threshold had a sensitivity of 42.6% (95% confidence interval (CI) 28.3 to 57.8; specificity 96.5%, 94.7 to 97.8). Compared with Risk of Malignancy Index 1 at the 250 threshold, CA 125 and all other tests had higher sensitivity (CA 125 at 87 IU\/mL threshold: 55.1%, 40.2 to 69.3, P=0.06; Risk of Malignancy Algorithm at 11.4% threshold: 79.2%, 65.0 to 89.5, P&lt;0.001; IOTA ADNEX at 10% threshold: 89.1%, 76.4 to 96.4, P&lt;0.001; IOTA simple rules risk at 10% threshold: 83.0%, 69.2 to 92.4, P&lt;0.001; IOTA simple rules: 75.0%, 56.6 to 88.5, P=0.01) and lower specificity (CA 125 at 87 IU\/mL threshold: 89.0%, 86.5 to 91.2, P&lt;0.001; Risk of Malignancy Algorithm at 11.4% threshold: 73.1%, 69.6 to 76.3, P&lt;0.001; IOTA ADNEX at 10% threshold: 75.1%, 71.4 to 78.6, P&lt;0.001; IOTA simple rules risk at 10% threshold: 76.0%, 72.4 to 79.3, P&lt;0.001; IOTA simple rules: 95.2%, 93.0 to 96.9, P=0.06). Results for IOTA simple rules were inconclusive in 120 of 799 participants. Analysis of the complete cohort (n=1211), including the 354 premenopausal women with a higher likelihood of developing ovarian cancer, yielded similar results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to Risk of Malignancy Index 1 at 250 threshold\u2014the test currently used in NHS secondary care to triage women to tertiary care\u2014most tests improve sensitivity but reduce specificity. Ultrasound triage with the IOTA ADNEX model at 10% in secondary care demonstrated the highest sensitivity gain, with a comparable decline in specificity to other comparator tests. Ultrasound with the IOTA ADNEX model at 10% should be considered the new standard of care test for triaging premenopausal women in secondary care. Implementation should incorporate staff training and quality assurance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"ISRCTN17160843\" ext-link-type=\"isrctn\">ISRCTN17160843<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj-2024-083912","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:30:26Z","timestamp":1769650226000},"page":"e083912","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study"],"prefix":"10.1136","volume":"392","clinical-trial-number":[{"clinical-trial-number":"isrctn17160843","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct06129968","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn17160843","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-3015","authenticated-orcid":false,"given":"Sudha","family":"Sundar","sequence":"first","affiliation":[{"name":"PanBirmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham B71 4HJ, UK"},{"name":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham B71 4HJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-5617","authenticated-orcid":false,"given":"Ridhi","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Applied Health Science, University of Birmingham, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-2805","authenticated-orcid":false,"given":"Katie","family":"Scandrett","sequence":"additional","affiliation":[{"name":"Department of Applied Health Science, University of Birmingham, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-4889","authenticated-orcid":false,"given":"Clare","family":"Davenport","sequence":"additional","affiliation":[{"name":"Department of Applied Health Science, University of Birmingham, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-7450","authenticated-orcid":false,"given":"Ben","family":"Van Calster","sequence":"additional","affiliation":[{"name":"Department of Development and Regeneration, KU Leuven, Leuven, Belgium"},{"name":"Leuven Unit for Health Technology Assessment Research (LUHTAR), KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4752-2255","authenticated-orcid":false,"given":"Susanne","family":"Johnson","sequence":"additional","affiliation":[{"name":"Southampton University Hospitals, NHS Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Durham and Darlington NHS Trust, Darlington, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Selvi-Vikram","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fong Lien","family":"Kwong","sequence":"additional","affiliation":[{"name":"PanBirmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham B71 4HJ, UK"},{"name":"Department of Applied Health Science, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-8200","authenticated-orcid":false,"given":"Sue","family":"Mallett","sequence":"additional","affiliation":[{"name":"Centre for Medical Imaging, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-9834","authenticated-orcid":false,"given":"Caroline","family":"Rick","sequence":"additional","affiliation":[{"name":"University of Nottingham, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-9532","authenticated-orcid":false,"given":"Sean","family":"Kehoe","sequence":"additional","affiliation":[{"name":"St Peter's College, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3707-6645","authenticated-orcid":false,"given":"Dirk","family":"Timmerman","sequence":"additional","affiliation":[{"name":"Department of Development and Regeneration, KU Leuven, Leuven, Belgium"},{"name":"Department of Obstetrics and Gynaecology, University Hospitals KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1421-6059","authenticated-orcid":false,"given":"Tom","family":"Bourne","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Stobart","sequence":"additional","affiliation":[{"name":"Patient Representative, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-2744","authenticated-orcid":false,"given":"Richard D","family":"Neal","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, University of Exeter, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-1732","authenticated-orcid":false,"given":"Usha","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Elizabeth Garrett Anderson Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-9762","authenticated-orcid":false,"given":"Aleksandra","family":"Gentry-Maharaj","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s Cancer, Elizabeth Garrett Anderson Institute for Women\u2019s Health, University College London, London, UK"},{"name":"MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1614-2988","authenticated-orcid":false,"given":"Lauren","family":"Sturdy","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-2145","authenticated-orcid":false,"given":"Ryan","family":"Ottridge","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-1971","authenticated-orcid":false,"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[{"name":"Department of Applied Health Science, University of Birmingham, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026012821300592000_392.jan28_7.e083912.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70041-4"},{"key":"2026012821300592000_392.jan28_7.e083912.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7400"},{"key":"2026012821300592000_392.jan28_7.e083912.3","unstructured":"International Agency for Research on Cancer (IARC). Global Cancer Observatory. 2024 [cited 18 Dec 2024]. https:\/\/gco.iarc.fr\/"},{"key":"2026012821300592000_392.jan28_7.e083912.4","unstructured":"National Ovarian Cancer Audit (NOCA). State of the Nation Report 2025. London: National Cancer Audit Collaborating Centre, Royal College of Surgeons of England, 2025"},{"key":"2026012821300592000_392.jan28_7.e083912.5","unstructured":"UK National Institute for Health and Care Excellence. Ovarian cancer: recognition and initial management | Clinical Guideline [CG122]. 2011 [cited 18 Dec 2024]. https:\/\/www.nice.org.uk\/guidance\/cg122"},{"key":"2026012821300592000_392.jan28_7.e083912.6","unstructured":"NHS England. NHS England Faster diagnosis. [cited 8 Oct 2025]. https:\/\/www.england.nhs.uk\/cancer\/faster-diagnosis\/"},{"key":"2026012821300592000_392.jan28_7.e083912.7","unstructured":"NHS England. NHS England Faster diagnostic pathways: Implementing a timed gynaecology cancer diagnostic pathway. Guidance for local health and care systems."},{"key":"2026012821300592000_392.jan28_7.e083912.8","unstructured":"NHS England. NHS Diagnostic Waiting Times and Activity Data. 2023 [cited 18 Dec 2024]. https:\/\/www.england.nhs.uk\/statistics\/wp-content\/uploads\/sites\/2\/2023\/05\/DWTA-Report-March-2023_OLEX2.pdf"},{"key":"2026012821300592000_392.jan28_7.e083912.9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123730"},{"key":"2026012821300592000_392.jan28_7.e083912.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb02448.x"},{"key":"2026012821300592000_392.jan28_7.e083912.11","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.70074"},{"key":"2026012821300592000_392.jan28_7.e083912.12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184362"},{"key":"2026012821300592000_392.jan28_7.e083912.13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21616"},{"key":"2026012821300592000_392.jan28_7.e083912.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.02.030"},{"key":"2026012821300592000_392.jan28_7.e083912.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.031"},{"key":"2026012821300592000_392.jan28_7.e083912.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5920"},{"key":"2026012821300592000_392.jan28_7.e083912.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6839"},{"key":"2026012821300592000_392.jan28_7.e083912.18","unstructured":"Royal College of Obstetricians and Gynaecologists. Ovarian Masses in Premenopausal Women, Management of Suspected (Green-top Guideline No 62). [cited December 2024]. https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/ovarian-masses-in-premenopausal-women-management-of-suspected-green-top-guideline-no-62\/"},{"key":"2026012821300592000_392.jan28_7.e083912.19","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001768"},{"key":"2026012821300592000_392.jan28_7.e083912.20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019191150"},{"key":"2026012821300592000_392.jan28_7.e083912.21","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23635"},{"key":"2026012821300592000_392.jan28_7.e083912.22","article-title":"Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women","volume":"7","author":"Davenport","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012821300592000_392.jan28_7.e083912.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00406-6"},{"key":"2026012821300592000_392.jan28_7.e083912.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527"},{"key":"2026012821300592000_392.jan28_7.e083912.25","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0697"},{"key":"2026012821300592000_392.jan28_7.e083912.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010333"},{"key":"2026012821300592000_392.jan28_7.e083912.27","doi-asserted-by":"publisher","DOI":"10.1021\/pr800545q"},{"key":"2026012821300592000_392.jan28_7.e083912.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.03.043"},{"key":"2026012821300592000_392.jan28_7.e083912.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003295"},{"key":"2026012821300592000_392.jan28_7.e083912.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.031"},{"key":"2026012821300592000_392.jan28_7.e083912.31","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230685"},{"key":"2026012821300592000_392.jan28_7.e083912.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.01.007"},{"key":"2026012821300592000_392.jan28_7.e083912.33","unstructured":"Gynaia. Accessed 21 January 2026. https:\/\/gynaia.com\/"},{"key":"2026012821300592000_392.jan28_7.e083912.34","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5969"},{"key":"2026012821300592000_392.jan28_7.e083912.35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.2000.00287.x"},{"key":"2026012821300592000_392.jan28_7.e083912.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074819"},{"key":"2026012821300592000_392.jan28_7.e083912.37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R"},{"key":"2026012821300592000_392.jan28_7.e083912.38","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2026012821300592000_392.jan28_7.e083912.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.02.011"},{"key":"2026012821300592000_392.jan28_7.e083912.40","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6787"},{"key":"2026012821300592000_392.jan28_7.e083912.41","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17813"},{"key":"2026012821300592000_392.jan28_7.e083912.42","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2024-005371"},{"key":"2026012821300592000_392.jan28_7.e083912.43","unstructured":"IOTA Plus. IOTA Plus NHS Training. 2024. https:\/\/iotaplus.org\/en\/iota-plus-nhs-training"},{"key":"2026012821300592000_392.jan28_7.e083912.44","doi-asserted-by":"publisher","DOI":"10.1002\/uog.26080"},{"key":"2026012821300592000_392.jan28_7.e083912.45","doi-asserted-by":"publisher","DOI":"10.1002\/uog.27641"},{"key":"2026012821300592000_392.jan28_7.e083912.46","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30837-4"},{"key":"2026012821300592000_392.jan28_7.e083912.47","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00723-X"},{"key":"2026012821300592000_392.jan28_7.e083912.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2614"},{"key":"2026012821300592000_392.jan28_7.e083912.49","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X14547233"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2024-083912","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2024-083912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:30:14Z","timestamp":1769664614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2024-083912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":49,"alternative-id":["10.1136\/bmj-2024-083912"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2024-083912","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}